Everything you need to know about TMS for Bipolar Depression: Promise, Precautions, and Current Evidence — how it works, what it costs, and how to find a provider who actually knows what they're doing.
TMS vs. Medication: A Side-by-Side Guide
Free PDF — compare effectiveness, side effects, cost, and timelines so you can choose with confidence.
Bipolar disorder affects approximately 2.8% of the adult population in the United States, and depressive episodes are often the most disabling aspect of the illness. Unlike unipolar depression, treating bipolar depression carries unique risks: antidepressant medications can trigger manic switches, rapid cycling, or mixed states. Transcranial magnetic stimulation may carry a lower switch risk than antidepressants, but its use in bipolar disorder requires careful consideration of the evidence and appropriate safety protocols.
Why TMS for Bipolar Depression Is Different
The neurobiology of bipolar depression differs from unipolar depression in several important ways. Bipolar disorder involves dysregulation of neural networks involved in emotional processing, reward circuitry, and circadian rhythms. The dorsolateral prefrontal cortex (DLPFC) shows reduced activity during depressive episodes in both conditions, but the connectivity patterns and underlying pathophysiology are distinct.
TMS for bipolar depression must therefore account for the illness’s unique features while minimizing any risk of inducing mania or hypomania. This requires different stimulation parameters and careful patient selection compared to standard TMS for major depressive disorder.
The Evidence Base
Early concerns that TMS might trigger manic episodes have not been borne out in the available studies, though the evidence base is small compared with unipolar depression:
- A 2021 systematic review and meta-analysis (Nguyen et al.; 14 studies, 274 patients) found a medium-sized benefit of rTMS over sham for clinical response (odds ratio about 2.7) and little risk of switching to mania. An earlier pooled analysis of 19 studies (181 patients) reported response rates of roughly 44% with active rTMS versus 25% with sham. A 2024 network meta-analysis of 12 sham-controlled trials has also examined response, remission, and mania incidence.
- A retrospective series of 44 bipolar patients treated in routine practice reported that no patient met criteria for a manic or mixed episode, although some stopped treatment because of activation. This type of data is uncontrolled and cannot show efficacy versus sham.
- Reviewers consistently note that trials are few and small, and that many were dominated by patients with unipolar depression.
The FDA has cleared TMS for treatment-resistant major depressive disorder but not specifically for bipolar depression, so use in bipolar disorder is off-label. Some clinicians offer TMS to bipolar patients who cannot tolerate or have not responded to mood stabilizers, with careful monitoring.
Safety Considerations: The Mania Question
The primary safety concern with TMS in bipolar disorder is the potential to induce manic or hypomanic episodes. However, the risk appears low when certain precautions are followed:
Safety protocols for bipolar TMS:
- Continuous mood monitoring throughout the treatment course
- Therapeutic blood levels of mood stabilizers (lithium, valproate, lamotrigine) during treatment
- Careful screening, since many clinicians avoid or take extra caution with recent manic episodes, mixed features, or rapid cycling
- Protocol choice made by the treating psychiatrist; there is no consensus that one stimulation pattern is safer than another
Accelerated Protocols and Novel Approaches
Traditional TMS protocols involve daily sessions over about 6 weeks, which can be burdensome for patients in severe depressive episodes. Accelerated protocols are being studied, mostly in unipolar depression:
Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT)
SAINT uses accelerated iTBS (intermittent theta burst stimulation) with 10 sessions per day over 5 days, combined with personalized targeting based on functional connectivity MRI. Its published trials were in treatment-resistant unipolar depression, and they excluded bipolar disorder, so SAINT results should not be assumed to apply to bipolar depression.
Bilateral TMS
Instead of targeting only the left DLPFC, bilateral protocols stimulate both left (high-frequency) and right (low-frequency) prefrontal regions. Whether bilateral stimulation offers any advantage in bipolar depression has not been established.
Deep TMS with H-Coils
Deep TMS uses H-coils that reach deeper and broader brain regions. The FDA cleared the BrainsWay Deep TMS system for major depressive disorder, not for bipolar depression, and evidence in bipolar depression is limited.
Clinical Recommendations
For clinicians considering TMS for bipolar depression, the following approach is recommended:
- Confirm the diagnosis and ensure bipolar disorder is not misdiagnosed unipolar depression
- Review psychiatric history to identify any recent manic episodes or rapid cycling
- Optimize mood stabilizer regimen before initiating TMS
- Use bilateral or right-sided protocols if concerns about mania risk are elevated
- Monitor mood daily using standardized scales during the treatment course
- Have a treatment plan for any emerging manic or hypomanic symptoms
Who May Benefit Most
Bipolar patients who are best suited for TMS include those with:
- Depression that has not responded adequately to mood stabilizers alone
- Intolerance to antidepressants due to side effects or documented manic switches
- Preferences for non-pharmacological treatments
The Bottom Line
TMS is an off-label option for bipolar depression that may offer antidepressant effects with a lower manic switch risk than antidepressant medications. Available evidence is limited but supports considering it in carefully selected patients with appropriate safety monitoring. As the field evolves, accelerated and personalized protocols may further improve outcomes for this challenging population.
For patients considering TMS for bipolar depression, understanding the full treatment landscape is important. Compare TMS to medications, explore success rates and outcomes, and find experienced providers who understand bipolar nuances. Review insurance coverage options and understand what TMS actually feels like. For treatment-resistant symptoms, maintenance protocols may prevent relapse. Combining TMS with therapy may be considered.
If you have bipolar disorder and are struggling with persistent depression, discuss TMS with your psychiatrist to determine whether it may be an appropriate treatment option for your specific situation.
